UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://epims.med.ubc.ca" title="UBC PiMS Research Group (the Tremlett Laboratory)" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/research/" title="Research">Research</a> <span class="sep">»</span> Media </div></div>

Media

JAMA Report: Beta Interferon Not Associated In Patients with Relapsing-Remitting MS

Researching with data from the B.C. MS Database

Prodromal Stage of Multiple Sclerosis

Ectrims 2024 Media Article by Stefania de Vito.

Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS

ReachMD, A US HealthConnect Company. Posted 8 Nov 2023
According to a recent study, psychiatric conditions like depression, anxiety, bipolar disorder, and schizophrenia may be early indicators of multiple sclerosis (MS) years before symptoms appear, which could enable the early diagnosis and treatment of patients with MS. Joining Dr. Charles Turck to share key details and findings from this study is Dr. Anibal Chertcoff. Not only is Dr. Chertcoff the lead author of the study, but he’s also a postdoctoral fellow at the University of British Columbia where his research centers on characterizing the multiple sclerosis prodrome.

Risk of Multiple Sclerosis in People with HIV: An International Cohort study.

E. Kingwell, A. Manouchehrinia, F. Zhu, K. McKay, J. Li, M. Ye, P. Sereda, J. Trigg, K. Kooij, M. Gisslén, A. Ekström, J. Hillert, R. Hogg, H. Tremlett. Risk of Multiple Sclerosis in People with HIV: An International Cohort study. Presentation Type: Oral Presentation. The ACTRIMS Forum 2023, San Diego, California, Conference Date: 2023/2

HIV-positive people found to be less likely to develop MS (posted March 1st 2023)

Understanding the Risk of Multiple Sclerosis in Patients with HIV (posted March 28th 2023)

Psychiatric comorbidity during the proximal period in patients with multiple sclerosis

A. Chertcoff, F. L. Yusuf, F. Zhu, C. Evans, J. D. Fisk, Y. Zhao, R. Marrie, H. TremlettPsychiatric comorbidity during the prodromal period in patients with multiple sclerosis. Neurology. 2023 Nov 14;101(20):e2026-e2034. doi: 10.1212/WNL.0000000000207843. Epub 2023 Sep 25. PMID: 37748884.

[IF=11.8 (2022)]

Editorial: How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice?
Raffaele Palladino, Eva M Strijbis. Neurology Sep 2023, 10.1212/WNL.0000000000207989; DOI: 10.1212/WNL.0000000000207989

Salient quote: Chertcoff et al. have to be commended for their effort at evaluating the psychiatric prodrome of MS using the combination of administrative and clinical data.

Select Media

VJNeurology ECTRIMS 2024 Interviews: https://www.vjneurology.com/speaker/helen-tremlett/

Faculty of Medicine: https://www.med.ubc.ca/news/depression-anxiety-may-be-among-early-signs-of-ms/

UBC Media Relations: https://news.ubc.ca/2023/09/26/depression-anxiety-may-be-among-early-signs-of-ms/

Large Study Suggests that Psychiatric Conditions May Provide Early Hints to a Future MS Diagnosis
US NMSS. September 25, 2023. https://www.nationalmssociety.org/About-the-Society/News/Large-Study-Suggests-that-Psychiatric-Conditions-M

Trainee (first author) interview:
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
ReachMD, A US HealthConnect Company. Posted 8Nov2023

According to a recent study, psychiatric conditions like depression, anxiety, bipolar disorder, and schizophrenia may be early indicators of multiple sclerosis (MS) years before symptoms appear, which could enable the early diagnosis and treatment of patients with MS. Joining Dr. Charles Turck to share key details and findings from this study is Dr. Anibal Chertcoff. Not only is Dr. Chertcoff the lead author of the study, but he’s also a postdoctoral fellow at the University of British Columbia where his research centers on characterizing the multiple sclerosis prodrome.

Could depression and anxiety be early signs of MS? Medical News Today (Oct 1st 2023)

Also covered locally: Vancouver is AwesomeRichmond NewsBurnaby NowTri-City NewsNorth Shore NewsSquamish ChiefDelta OptimistNew Westminster RecordPowell River Peak, Alaska Highway News and in the USA: US News & World Report.

Person living with MS who works at UBC (shared with UBC media), demonstrates the impact this work is having on people.

“I am a patient at the Centre for Brain Health. I wanted to thank you for the article you wrote about MS research. In the absence of other symptoms, I have had a hard time coming to terms with my diagnosis. The great research happening within the Faculty of Medicine is one of the reasons I’m proud to work at UBC and grateful for the care I receive there. I have shared your article with friends and family, and hope it will help them understand, just as it has helped me. Thank you.”

Dr. Helen Tremlett on TV

TV and Radio interviews related to high-impact publications, Citizen Engagement
Target Stakeholder: General Public

Radio interviews related to my senior author Lancet Neurology 2017 paper (Lancet Neurol. 2017 Jun;16(6):445-451.). Impact factor of 23. Ranked #1 clinical neurology journal (from 193)

May 2017. Radio interview: News 1130http://www.news1130.com/2017/05/07/ medical-problems-common-ms-patients-diagnosis-ubc/

April 2017. Live radio interview:Roundhouse Vancouver. Evenings With Kirk LaPointe – Helen Tremlett senior author of the studyand a professor at UBC talks about the study and how it hopes to impact treatment for MS (http://bit.ly/2p4opbo)

Four T.V. interviews (live on CTV National, taped on multiple evening news networks), and extensive interviews and news coverage, including the NewYork Times,Globe and Mail, Vancouver Sun. Related to my senior author paper in JAMA 2012 (Impact factor 44.4; ranked 3rd of 150 medical journals worldwide).

Podcasts (invited)

The ECTRIMS Podcast. Nov 2024.
Podcast: Episode 38: MS Prodrome: Implications and Future Research Directions
Podcast Host: Brett Drummond, PhD. Co-Founder & Science Communicator, MSTranslate via ECTRIMS, Melbourne, Australia
https://ectrims.eu/podcast/. Podcast released 07th Nov 2024 (https://ectrims.eu/podcast/episode-38/)

MS Living Well podcast. May 2023.
Topic: The MS prodrome
Podcast Host: Barry A. Singer, MD. Director, The MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, USA
www.mslivingwell.org. podcast released 15th May 2023 (https://apple.co/3HSl1Z4)
>850 downloads within a week of the release

Real Talk MS podcast. October 2023.
Podcast: Episode 321: More from the 2023 Joint ECTRIMS-ACTRIMS Meeting with Dr. Helen Tremlett
Topic: ECTRIMS Hot Topic: The MS prodrome. Live interview, Milan, Italy
Jon Strum, Podcast Host
www.RealTalkMS.com; direct link (released 23-Oct-2023):https://realtalkms.com/321

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia